Home › Financial Statements › Notes to and forming part of the financial statements: Note 17. Reporting of Outcomes
Notes to and forming part of the financial statements
For the year ended 30 June 2007
- Note 1: Summary of Significant Accounting Policies
- Note 2: Economic Dependency
- Note 3: Events Occuring After Reporting Date
- Note 4: Income
- Note 5: Operating Expenses
- Note 6: Financial Assets
- Note 7: Non-Financial Assets
- Note 8: Provisions
- Note 9: Payables
- Note 10: Cash Flow Reconciliation
- Note 11: Director Remuneration
- Note 12: Related Party Disclosures
- Note 13: Executive Remuneration
- Note 14: Remuneration of Auditors
- Note 15: Average Staffing Levels
- Note 16: Financial Instruments
- Note 17: Reporting of Outcome
Note 17: Reporting of Outcomes
Note 17A: Outcomes of the Corporation
Corporation activity involves the identification, co-ordination, funding and evaluation of research and development for Australia's grain industries. These financial statements provide a detailed overview of the Corporation's total financial operations for the year ended 30 June 2007. The Corporation operates predominantly in one industry, the grains industry and in one geographical area being Australia.
Outcome 1 – Through its commitment to innovation, an Australian grains industry that is profitable and environmentally sustainable for the benefit of the industry and wider community.
Four outputs are identified for the above outcome. These are:
| Outcome 1 | Total | |||
|---|---|---|---|---|
| 2007 | 2006 | 2006 | 2005 | |
| Expenses | $'000 | $'000 | $'000 | $'000 |
| Departmental expenses | 115,865 | 126,720 | 115,865 | 126,720 |
| Total expenses | 115,865 | 126,720 | 115,865 | 126,720 |
| Other external revenues | ||||
| Departmental | ||||
| Interest | 5,015 | 5,673 | 5,015 | 5,673 |
| Industry contributions | 50,868 | 60,861 | 50,868 | 60,861 |
| Project refunds | 3,272 | 1,533 | 3,272 | 1,533 |
| Royalties | 2,181 | 3,516 | 2,181 | 3,516 |
| Other | 300 | 488 | 300 | 488 |
| Total other external revenues | 61,636 | 72,071 | 61,636 | 72,071 |
| Total other external revenues | 61,636 | 72,071 | 61,636 | 72,071 |
| Net cost/(contribution) of outcome | 54,229 | 54,649 | 54,229 | 54,649 |
| Outcome 1 | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Output 1 | Output 2 | Output 3 | Output 4 | |||||||
| 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | 2007 | 2006 | |
| $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | $'000 | |
| Operating expenses | ||||||||||
| Research and development | 52,477 | 58,887 | 35,771 | 37,211 | 8,686 | 11,662 | 6,090 | 7,570 | 103,024 | 115,330 |
| Employees | 1,409 | 1,369 | 1,408 | 1,368 | 1,408 | 1,368 | 1,409 | 1,368 | 5,634 | 5,473 |
| Suppliers | 1,318 | 1,149 | 1,434 | 1,267 | 1,128 | 936 | 1,183 | 1,972 | 5,063 | 5,324 |
| Depreciation and amortisation | 142 | 106 | 143 | 106 | 143 | 106 | 143 | 106 | 571 | 424 |
| Write-down of assets | 1226 | 169 | - | 0 | 130 | 0 | - | 0 | 1,356 | 169 |
| Share of operating results (equity method) | - | - | - | - | 217 | - | - | - | 217 | - |
| Total operating expenses | 56,572 | 61,680 | 38,756 | 39,952 | 11,712 | 14,072 | 8,825 | 11,016 | 115,865 | 126,720 |
| Funded by | ||||||||||
| Revenues from Government | 18,219 | 21,988 | 12,419 | 13,895 | 3,016 | 4,355 | 2,114 | 2,827 | 35,768 | 43,065 |
| Interest | 2,555 | 2,897 | 1,741 | 1,830 | 423 | 574 | 296 | 372 | 5,015 | 5,673 |
| Industry contributions | 25,910 | 31,075 | 17,662 | 19,637 | 4,289 | 6,154 | 3,007 | 3,995 | 50,868 | 60,861 |
| Project Refunds | 1,843 | 634 | 601 | 491 | 541 | 327 | 287 | 81 | 3,272 | 1,533 |
| Royalties | 545 | 879 | 545 | 879 | 545 | 879 | 546 | 879 | 2,181 | 3,516 |
| Other | 75 | 122 | 75 | 122 | 75 | 122 | 75 | 122 | 300 | 488 |
| Total operating revenues | 49,147 | 57,595 | 33,043 | 36,854 | 8,889 | 12,411 | 6,325 | 8,276 | 97,404 | 115,136 |
The Corporation’s outcomes and outputs are described at Note 17A.
The Corporation uses actual expenses for the allocation of Research and Development expenses and some supplier expenses. All other expenses are apportioned across outputs evenly. Revenues uses actual income for allocation of project refunds, reversals of previous asset write-down and some other income. All other revenue is apportioned across outputs based on Research and Development expenditure.

